These 4 risk factors may increase your chance of long COVID, study hints By Nicoletta Lanese published 1 February 22 Several of these factors can be screened for in a patient's blood.
'Stealth' omicron is in the US. Here's what we know about it. By Nicoletta Lanese published 26 January 22 Early data hint that the mutant is slightly more transmissible.
Can CBD really prevent COVID-19 infection? Scientists hope to find out. By Stephanie Pappas published 25 January 22 Cannabidiol (CBD), an active ingredient in cannabis, might help block infection with the virus that causes COVID-19.
COVID-19 may trigger diabetes by causing fat cells to go haywire By Nicoletta Lanese published 20 January 22 The coronavirus may cause fat cells to malfunction.
Omicron's not the last variant we'll see. Will the next one be bad? By Nicoletta Lanese published 12 January 22 It's difficult to predict what combination of traits such a variant might have.
Will omicron wipe out delta forever? By Stephanie Pappas published 7 January 22 Omicron is sweeping away the delta variant, having impacts on hospitalization and population immunity.
Rapid tests may not detect omicron early in infection By Nicoletta Lanese published 6 January 22 However, PCR tests, which are more sensitive, detected the virus in the early days of infection.
Omicron may cause milder disease. A lab study hints at why. By Nicoletta Lanese published 25 December 21 The omicron variant of SARS-CoV-2 may be less efficient at infiltrating the lungs and spreading from cell to cell, early lab studies suggest.
Breakthrough COVID cases may supercharge immunity, study hints By Nicoletta Lanese published 17 December 21 There may be a silver lining to breakthrough infections, although they obviously still carry risks.
The coronavirus infects fat cells, study suggests By Nicoletta Lanese published 9 December 21 Yet-to-be-reviewed research suggests the coronavirus infects fat cells and certain immune cells in fat.
Newfound flavor of omicron variant may be harder to track By Nicoletta Lanese published 8 December 21 The newfound version, BA.2, may be slightly harder to track.
Omicron variant may have evolved in rats, one theory says By Nicoletta Lanese published 2 December 21 Some features of the omicron variant's genome hint that it may have evolved in rodents.
1st case of omicron variant in US confirmed in California By Yasemin Saplakoglu published 1 December 21 U.S. officials confirmed the first U.S. case of omicron in California.
The Omicron variant: What we know so far By Yasemin Saplakoglu published 29 November 21 On Nov. 26, the World Health Organization (WHO) named a new coronavirus variant "Omicron" and designated it as a "variant of concern."
FDA authorizes Pfizer and Moderna COVID-19 booster shots for all adults By Yasemin Saplakoglu published 19 November 21 On Friday (Nov. 19), The Food and Drug Administration (FDA) authorized Moderna and Pfizer boosters for all adults, prior to the busy holiday season.
California and Colorado start COVID-19 booster shots for all adults By Yasemin Saplakoglu published 12 November 21 California and Colorado expanded booster shot eligibility to all adults who received their second dose of Moderna's or Pfizer's COVID-19 vaccine at least six months ago.
Antiviral pill cuts COVID-19 hospitalizations and deaths by 89%, Pfizer says By Yasemin Saplakoglu published 5 November 21 A new COVID-19 pill significantly cuts risk of hospitalization or death when taken within three days of symptom onset, Pfizer says.
FDA panel recommends Pfizer vaccine for children ages 5 to 11 By Yasemin Saplakoglu published 26 October 21 The FDA panel concluded that the benefits of Pfizer's COVID-19 vaccine for young children outweigh the risks.
'Rogue' antibodies found in brains of teens with delusions and paranoia after COVID-19 By Nicoletta Lanese published 25 October 21 Autoantibodies may sometimes be involved in the psychiatric effects of COVID-19.
Moderna says COVID-19 vaccine is safe and effective in children By Yasemin Saplakoglu published 25 October 21 The company plans to submit their data to regulatory agencies soon.
